Antifungal resistance of Candida glabrata vaginal isolates and development of a quantitative reverse transcription-PCR-based azole susceptibility assay

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 9, 2008, Pages 3424-3426

  Gygax, Scott E ^a,c   Vermitsky, John Paul ^a   Chadwick, Sean G ^a   Self, Matthew J ^a   Zimmerman, Jessica A ^c   Mordechai, Eli ^c   Adelson, Martin E ^c   Trama, Jason P ^b  

^a Antimicrobial Resistance Division   (United States)

^b Molecular and Cellular Biology Division   (United States)

^c LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE; MICONAZOLE; VORICONAZOLE;

ANTIFUNGAL RESISTANCE; ARTICLE; BROTH DILUTION; CANDIDA GLABRATA; CDR1 GENE; GENE; GENE EXPRESSION; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VAGINA;

ANTIFUNGAL AGENTS; AZOLES; CANDIDA GLABRATA; CANDIDIASIS, VULVOVAGINAL; DRUG RESISTANCE, FUNGAL; FEMALE; FLUCONAZOLE; FUNGAL PROTEINS; GENE EXPRESSION REGULATION, FUNGAL; HUMANS; MEMBRANE TRANSPORT PROTEINS; MICROBIAL SENSITIVITY TESTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; UP-REGULATION; VAGINA;

EID: 50949121817     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00462-08     Document Type: Article

References (21)

1. Bader, M. S., S. M. Lai, V. Kumar, and D. Hinthorn. 2004. Candidemia in patients with diabetes mellitus: epidemiology and predictors of mortality. Scand. J. Infect. Dis. 36:860-864.
2. Banerjee, S. N., T. G. Emori, D. H. Culver, R. P. Gaynes, W. R. Jarvis, T. Horan, J. R. Edwards, J. Tolson, T. Henderson, and W. J. Martone. 1991. Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. National Nosocomial Infections Surveillance System. Am. J. Med. 16:86S-89S.
3. Berrouane, Y. F., L. A. Herwaldt, and M. A. Pfaller. 1999. Trends in antifungal use and epidemiology of nosocomial yeast infections in a university hospital. J. Clin. Microbiol. 37:531-537.
4. Dan, M., R. Segal, V. Marder, and A. Leibovitz. 2006. Candida colonization of the vagina in elderly residents of a long-term-care hospital. Eur. J. Clin. Microbiol. Infect. Dis. 25:394-396.
5. Goswami, D., R. Goswami, U. Banerjee, V. Dadhwal, S. Miglani, A. A. Lattif, and N. Kochupillai. 2006. Pattern of Candida species isolated from patients with diabetes mellitus and vulvovaginal candidiasis and their response to single dose oral fluconazole. J. Infect. 52:111-117.
6. Kao, A. S., M. E. Brandt, W. R. Prutti, L. A. Conn, B. A. Perkins, D. S. Stephens, W. S. Baughman, A. L. Reingold, G. A. Rothrock, M. A. Pfaller, R. W. Pinner, and R. A. Hajjeh. 1999. The epidemiology of candidemia in two U.S. cities: results of a population-based active surveillance. Clin. Infect. Dis. 29:1164-1170.
7. Kofla, G., and M. Ruhnke. 2007. Development of a new real-time TaqMan PCR assay for quantitative analyses of Candida albicans resistance genes expression. J. Microbiol. Methods 68:178-183.
8. Miyazaki, H., Y. Miyazaki, A. Gerber, T. Parkinson, C. Hitchcock, D. J. Falconer, D. J. Ward, K. Marsden, and J. E. Bennet. 1998. Fluconazole resistance associated with drug efflux and increased transcription of a drug transporter gene, PDH1, in Candida glabrata. Antimicrob. Agents Chemother. 42:1695-1701.
9. NCCLS/CLSI. 2002. Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard, 2nd ed., M27-A2. NCCLS/CLSI, Wayne, Pa.
10. Ostrosky-Zeichner, L., J. H. Rex, P. G. Pappas, R. J. Hamill, R. A Larsen, H. W. Harold, W. G. Powderly, N. Hyslop, C. A. Kauffman, J. Cleary, J. E. Mangino, and J. Lee. 2003. Antifungal susceptibility survey of 2000 blood-stream Candida isolates in the United States. Antimicrob. Agents Chemother. 47:3149-3154.
11. Park, S., and D. S. Perlin. 2005. Establishing surrogate markers for fluconazole resistance in Candida albicans. Microb. Drug Resist. 11:232-238.
12. Pfaller, M. A., D. J. Diekema, J. H. Rex, A. Espinel-Ingroff, E. M. Johnson, D. Andes, V. Chaturvedi, M. A. Ghannoum, F. C. Odds, M. G. Rinaldi, D. J. Sheehan, P. Troke, T. J. Walsh, and D. W. Warnock. 2006. Correlation of MIC with outcome for Candida species tested against voriconazole: analysis and proposal for interpretive breakpoints. J, Clin. Microbiol. 44:819-826.
13. Ray, D., R. Goswami, U. Banerjee, V. Dadhwal, D. Goswami, P. Mandal, V. Sreenivas, and N. Kochupillai. 2007. Prevalence of Candida glabrata and its response to boric acid vaginal suppositories in comparison with oral fluconazole in patients with diabetes and vulvovaginal candidiasis. Diabetes Care 30:312-317.
14. Redding, S. W., W. R. Kirkpatrick, S. Seville, B. J. Coco, W. White, A. FothergiII, M. Rinaldi, T. Eng, T. F. Patterson, and J. Lopez-Ribot. 2003. Multiple patterns of resistance to fluconazole in Candida glabrata isolates from a patient with oropharyngeal candidiasis receiving head and neck radiation. J. Clin. Microbiol. 41:619-622.
15. Richter, S. S., R. P. Galask, S. A. Messer, R. J. Hollis, D. J. Diekema, and M. A. Pfaller. 2005. Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of recurrent cases. J. Clin. Micobiol. 45(5): 2155-2162.
16. Safdar, A., D. Armstrong, E. W. Cross, and D. S. Perlin. 2002. Prospective epidemiologic analysis of triazole-resistant nosocomial Candida glabrata isolated from patients at a comprehensive cancer center. Int. J. Infect. Dis. 6:198-201.
17. Sanglard, D., F. Ischer, D. Calabrese, P. A. Majcherczyk, and J. Bille. 1999. The ATP binding cassette transporter gene CgCDR1 from Candida glabrata is involved in the resistance of clinical isolates to azole antifungal agents. Antimicrob. Agents Chemother. 43:2753-2765.
18. Sariguinetti, M., B. Posteraro, B. Fiori, S. Ranno, R. Torelli, and G. Fadda. 2005. Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance. Antimicrob. Agents Chemother. 49:668-679.
19. Vermitsky, J.-P., and T. D. Edlind. 2004. Azole resistance in Candida glabrata: coordinate upregulation of multidrug transporters and evidence for a Pdr1-like transcription factor. Antimicrob. Agents Chemother. 48(10):3773-3781.
20. Vermitsky, J.-P., T. Liu, T. D. Edlind, and P. D. Rogers. 2006. PDR1 regulates multidrug resistance in Candida glabrata: gene disruption and genome-wide expression studies. Mol. Microbiol. 61:704-722.
21. Wisplinghoff, H., T. Bischoff, S. M. Tallent, H. Seifert, R. P. Wenzel, and M. B. Edmond. 2004. Nosocomial bloodstream infections in U.S. hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin. Infect. Dis. 39:309-317.